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Medicine, Houston, Texas
Micropuncture study of the handling of gentamicin by the rat
kidney. Renal clearance and micropuncture studies were per-
formed in rats infused with 3H-gentamicin in order to examine
the renal handling of this aminoglycoside antibiotic. In non-
diuretic control animals, the fractional delivery of ultrafilterable
gentamicin averaged 65.5 5.3, 30.7 3.7, and 79.7 1.6% to
the late proximal tubule, distal tubule, and urine, respectively.
The same pattern of fractional delivery was found in rats loaded
with unlabeled gentamicin (60 mg/kg, i.m.) for 3 days. The ad-
ministration of furosemide (15 mg/kglhr) did not affect the deliv-
ery of gentamicin out of the late proximal tubule but did increase
distal delivery to 51.2 4.4% (P < 0.001, compared with con-
trol). The fractional excretion of gentamicin in the urine in those
animals was 79.1 3.0% (P = NS compared with controls, P <
0,001 compared with distal tubule). The infusion of isotonic sa-
line (3% of body wt per hour) increased the fractional excretion
of gentamicin in the urine to 103.4 3.3% (P < 0.001 compared
with controls) but did not alter the pattern of delivery along the
superficial proximal tubule. By contrast to saline, however, in
animals receiving sodium bicarbonate, the distal delivery of gen-
tamicin was higher (80.6 6.5% vs. 27.8 3.4%, P < 0.001).
These studies suggest that filtered gentamicin is reabsorbed in
the superficial proximal tubule and at nephron sites between the
proximal and distal tubules. Expansion of the extracellular fluid
volume with saline or bicarbonate results in an increase in the
urinary fractional excretion of gentamicin despite widely dif-
fering delivery rates to the superficial distal tubule. In all studies,
the fractional excretion of gentamicin in the urine exceeds the
delivery of the drug to the superficial distal tubule, suggesting
either nephron heterogeneity or secretion of the drug in nephron
segments beyond the superficial distal tubule. Finally, the uri-
nary excretion of gentamicin does not correlate with changes in
rates of absorption in superficial nephrons, suggesting that the
reabsorptive rates in deep nephrons are a more important de-
terminant of the rates of drug elimination.
Etude par microponction du comportement du rein de rat vis-I-
vis de Ia gentamicine. Des clearances et des microponctions ont
été réalisées chez Ic rat perfuse avec de la gentamicine tritiée
afin de pouvoir étudier le comportement renal de cet antibiotique
aminoglycoside. Chez les animaux contrôles non diurétiques, les
debits fractionnels de gentalnicine étaient respectivement de
65,5 5,3, 30,7 3,7, et 79,7 1,6% ala fin du tube proximal,
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du tube distal et dans l'urine definitive. Le méme aspect de dé-
bits fractionnels a été observe chez des rats recevant de la gen-
tamicine non marquee (60 mg/kg i.m.) pendant trois jours.
L'administration de furosémide (15 mg/kg/hr) n'a pas affecté Ic
debit de gentamicine a Ia fin du tube proximal mais a augmentC le
debit distal a 51,2 4,4% (P < 0,001, par rapport aux contrôles).
L'excrétion fractionnelle de gentamicine dans l'urine de ces ani-
maux était de 79,1 3,0% (P = NS par comparaison aux con-
trôles, P < 0,001 par comparaison au tube distal). La perfusion
de chlorure de sodium isotonique (3% de poids corporel par
heure) a augmenté l'excrétion fractionnelle de gentamicine dans
l'urine a 103,4 3,3% (P < 0,001 par comparaison aux con-
trôles) mais n'a pas modiflé l'aspect des debits Ic long du tube
proximal superficiel. A Ia difference dii chlorure de sodium, Ic
bicarbonate de sodium augmente le debit de gentamicine (80,6
6,5% au lieu de 27,8 3,4%, P < 0,001). Ces résultats peuvent
suggérer que Ia gentamicine filtrée est réabsorbée dans Ic tube
proximal superficiel et dans les segments du néphron situés entre
le proximal et le distal. L'expansion des liquides extracellulaires
avec chiorure de sodium ou bicarbonate de sodium determine
une augmentation de l'excrétion fractionnelle unnaire en dépit
de debits délivrés au tube distal trés diffdrents. Dans tous les cas
l'excrétion fractionnelle de gentamicine dans l'urine est supé-
rieure au debit au tube distal superficiel, cc qui suggêre soit
l'hétérogénéite de Ia population des néphrons, soit une sécré-
tion dans des segments situés en aval du tube distal superficiel.
Enfin, l'excrétion urinaire de gentamicine n'est pas corrélée
avec des modifications de Ia reabsorption dans les néphrons su-
perficiels, cc qui suggére que les debits de reabsorption dans les
néphrons profonds sont un determinant plus important du debit
d'élimination de la drogue.
The aminoglycoside antibiotics are a group of
polybasic compounds that have been used in the
treatment of infections due to Gram-negative bac-
teria. Gentamicin, one of the prototype drugs of this
group, has been studied extensively, for both its
nephrotoxicity and its pharmacokinetics [1-3]. Few
studies, however, have examined in great detail the
renal handling of gentamicin, even though its major
route of excretion is by the kidneys. Some clear-
ance studies in man and in laboratory animals have
demonstrated a clearance rate similar to that of in-
ulin or creatinine [1, 4, 5] indicating no net reab-
sorption or secretion of the drug. Other studies,
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however, have found net reabsorption of gen-
tamicin by the kidney [6, 7] or have suggested net
renal secretion of the drug [8]. The reasons for these
discrepancies are unclear but have been attributed,
at least in part, to different estimates of the protein
binding of gentamicin [4, 6, 8-10].
It seems well established now that gentamicin ac-
cumulates within the cells of the renal cortex, espe-
cially those of the proximal tubule [6, 11, 12]. Evi-
dence to date would indicate that the drug may gain
access to the cell from both the luminal and anti-
luminal surface. At the luminal surface, gentamicin
is taken up by the brush border, transported into the
cell by pinocytosis, and eventually incorporated into
the lysosomes [12, 13]. Studies in renal cortical slice
preparations have demonstrated that gentamicin
may be actively transported across the antiluminal
border of the cells and concentrated within the cells
[14, 15]. It is unclear at the present time, however,
whether or not gentamicin, taken up at the anti-
luminal border, can gain access to the tubular fluid.
More recently, intratubular microinjection stud-
ies in the rat have been reported that have attempt-
ed to directly examine the renal tubular transport
characteristics of gentamicin and to localize the
nephron sites of reabsorption [4]. The current free-
flow micropuncture studies were performed to ex-
tend these initial observations and to examine the
renal handling of gentamicin, delineate the nephron
sites of its transport, and to examine various factors
that may modify its rate of excretion.
Methods
All studies were performed in male Sprague-
Dawley rats that had free access to food and water
prior to study. Animals were anesthetized with pen-
tobarbital sodium (50 mg/kg of body wt, i.p.) and
prepared for micropuncture as previously described
[16]. A tracheostomy was performed, the jugular
veins were cannulated, and the urinary bladder was
catheterized. The left kidney was approached
through a flank incision, the perirenal fat and cap-
sule were stripped, and the kidney was immobilized
in 2% agar in a plastic cup. Body temperature was
maintained at 37° C. During preparation of the ani-
mals, a volume of isotonic saline equal to 1% of
body wt was infused i.v. as replacement for surgical
losses of fluid.
Each animal received a loading dose of 1 ml of
isotonic saline containing inulin [14C]-carboxylic
acid (75 pCiJml) (Amersham Searle Corp., Arling-
ton Heights, Illinois) and [G-8H]-gentamicin sulfate
(75 j.CiIml, 514 or 508 mCi/mmole) (Amersham
Searle), followed by a sustaining infusion of the
same solution at a rate of 1.2 mI/hr for the duration
of the study. 1 Five separate groups of animals were
studied.
Group 1 (N = 10): Nondiuretic controls. After a
90-mm equilibration period, free-flow micro-
puncture samples were obtained during three 30-
mm periods. Following each tubular puncture, a
blood sample was obtained from the tail vein for
analysis of '4C and 3H counts. Timed urine samples
were also obtained during the three 30-mm periods,
and the blood sample obtained at the midpoint of
each period was used to calculate the clearance rate
of inulin and gentamicin. Micropuncture samples
were obtained from late proximal and distal con-
voluted tubules in a random sequence. Proximal tu-
bules were localized by the intratubular injection of
small droplets of Sudan-black-stained mineral oil
and were considered to be late portions of the proxi-
mal tubule if the oil droplet immediately dis-
appeared below the surface of the kidney and did
not reappear [17]. The distal tubule was identified
following the i.v. injection of 0.05 ml of 2% lissa-
mine green dye.
Group 2 (N = 9): Furosemide. At the beginning of
the experiment, furosemide was infused i.v. in a
dose of 15 mg/kg of body wt as a bolus and was
followed by a sustaining infusion of 15 mg/kg of
body wt per hour. Urinary losses were replaced by
a volume of isotonic saline equal to the urinary flow
rate. Following a 90-mm equilibration period, clear-
ance and micropuncture studies were performed in
a manner similar to that in the control animals.
Groups 3 and 4 (N = 14): Volume expansion. At
the start of the experiment, isotonic sodium bi-
carbonate (7 animals) or isotonic sodium chloride (7
animals) was infused continuously throughout the
experiment at a rate equal to 3% of body wt per
hour. Following a 90-mm equilibration period, clear-
ance and micropuncture studies were performed in
a manner similar to that in the control animals.
Group 5 (N = 6): Gentamicin. Unlabeled gen-
tamicin, 60 mg/kg of body wt per day, was adminis-
tered i.m. for 3 days prior to study. These doses
previously have been shown to result in significant
tissue concentrations of drug in this strain of rat
'Two lots of radiolabeled gentamicin were obtained from the
manufacturer. Although the commercially available gentamicin
is a heterogeneous mixture of gentamicin C,, CiA, and C2, control
experiments were performed with both lots, and the results were
found to be identical. Thus, the data obtained from studies of
both lots of radiolabeled gentamicin were combined.
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[11]. On the day of experiment, the animals were
prepared for micropuncture in the same manner as
that for control animals. Following a 90-mm equili-
bration period, clearance and micropuncture stud-
ies were performed during three 30-mm periods. In
this group of animals, blood and urine concentra-
tions of gentamicin were also determined by radio-
immunoassay, and the gentamicin clearances calcu-
lated from these determinations were not signifi-
cantly different than those obtained by isotope
clearances.
At the conclusion of all experiments, a large
blood sample was obtained from the abdominal
aorta to study the ultrafilterability of gentamicin in
each individual animal. This was determined with
serum rather than plasma, because anticoagulants
have been shown to affect the ultrafilterability of
gentamicin [9]. One microliter of serum was
counted for total 3H and 14C radioactivity. The re-
maining serum was then centrifuged through a CF
50A membrane cone (Amicon Corp., Lexington,
Massachusetts) that had been soaked in distilled
water for 60 mm to remove the glycerin remaining
in the filter after manufacture. The membrane was
loaded with 4 to 5 ml of serum and centrifuged at X
750g for 20 mm at 40 C. One microliter of the pro-
tein-free filtrate (PFF) was then counted for total 3H
and 14C radioactivity. The ultrafilterability of 3H-
gentamicin was then calculated from the formula:
—
3H/'4C in PFFUFcntamicin —
3H/14C in serum
X 100.
In a separate series of experiments, the protein
binding of gentamicin was determined by equilibri-
um dialysis. Radiolabeled gentamicin was added to
1-mi aliquots of pooled rat serum in concentrations
of 0.5, 1.0, and 5.0 jg/ml. These aliquots were then
dialyzed against 3 ml of Ringer's solution containing
physiologic concentrations of calcium and magne-
sium for 24 hours at 37° C. Twenty microliters of
serum and uitrafiltrate were counted for total 3H ra-
dioactivity, and the ultrafilterability of gentamicin
was calculated from the formula:
3H in UF
UFGentamicin 3 . x 100.H in serum
Radioactivity of blood, tubular fluid, and urine
was determined in Biofluor (New England Nuclear,
Boston, Massachusetts) in a tricarb liquid scintilla-
tion counter (Packard Instruments Co., Inc., Down-
ers Grove, Illinois). Counts per minute were con-
verted to disintegrations per minute (dpm) after cor-
rection for quenching, crossover counts, and
efficiency of counting for each isotope. The clear-
ance of ultrafilterable 3H was taken to be the clear-
ance of gentamicin, because prior studies have in-
dicated that gentamicin is not metabolized and is
excreted unchanged by the kidneys [1, 18].
Urine pH was determined by a pH meter (lonaly-
zer, Orion Research, Inc., Cambridge, Massachu-
setts). Urine sodium and potassium concentrations
were measured by flame photometry. The GFR and
clearance rate of gentamicin are expressed as mi-
croliters per minute per gram of kidney weight and
are calculated from standard formulae and cor-
rected for the protein binding of gentamicin mea-
sured in each particular animal. Fractional excre-
tion, expressed as a percentage of the filtered load,
was calculated from the clearance rates of gen-
tamicin and inulin. The fractional delivery (FD) of
gentamicin to the point of micropuncture was calcu-
lated from the formula:
FD(%) = TF/UFG x 100
where TF and P are the disintegrations per minute
in the tubular fluid (TF), ultrafiltrate (UF) and
plasma (P) of gentamicin (G) and inulin (In). Abso-
lute absorptive rates of gentamicin to the point of
micropuncture were calculated from the formula:
absolute reabsorption (pg/ni GFR)
—
FL x (1 — FD)
-
SNGFR
where SNGFR is the single nephron filtration rate
(nl/,nin), (1 — FD) is the fractional rate of reabsorp-
tion of gentamicin to the point of micropuncture,
and FL is the filtered load of gentamicin calculated
from the single nephron GFR and the concentration
of gentamicin in the ultrafiltrate of serum. Concen-
trations of gentamicin in ultrafiltrates, tubular fluid,
and urine were calculated from the disintegrations
per minute of 3H and the known specific activity of
the infused isotope. Because group 5 animals had
been loaded with unlabeled gentamicin, the abso-
lute absorptive rates could not be calculated from
the specific activity of the isotope. In these animals,
the concentration of ultrafilterable gentamicin was
determined by radioimmunoassay. Whole kidney
absorptive rates were calculated from an analogous
formula and are expressed as picograms per micro-
liter of GFR. Statistical analysis was determined by
Student's t test for unpaired data.
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Results
Table 1 compares the disintegrations per minute
of gentamicin in the plasma and the fractional rate
of excretion in the first and last clearance periods in
each group of animals. For the animals as a whole,
as well as in each subgroup, these values were not
statistically different. Thus, no time-dependent
changes in plasma level or renal clearance of the
drug were observed.
The ultrafilterability of gentamicin determined by
centrifugation in the control group of animals aver-
aged 85.3 3.9%. Group 5 animals had a higher
ultrafilterability of gentamicin (94.5 2.4%, P <
0.05 compared with control), whereas animals in
groups 2, 3, and 4 had values not significantly dif-
ferent than control. When determined by equilibri-
um dialysis, the ultrafilterability of gentamicin aver-
aged84.7±3.5%(N4),94.1
92.5 3.8% (N = 4) in pooled rat serum containing
0.5, 1.0, and 5.0 jg of 3H-gentamicin per milliliter,
respectively.
The results of clearance and micropuncture stud-
ies are shown on Tables 2 and 3. In control, non-
diuretic animals, the fractional delivery rate of gen-
tamicin to the late portion of the proximal tubule
averaged 65.5 5.3%. The fractional delivery to
the distal tubule averaged 30.7 3.7% (P < 0.001
compared with the late proximal tubule). There was
no relationship between the fractional rate of gen-
tamicin delivery and TF/P1 values in samples ob-
tained from the distal convoluted tubules, indicating
that there is no net transport of the drug in this
nephron segment. The fractional excretion of gen-
tamicin in the urine was 79.7 1.6%, a value signif-
icantly higher than that in the distal tubule.
The infusion of furosemide, 15 mg/kg of body wt
per hour, resulted in a higher rate of sodium excre-
tion in the urine (8.44 0.62 Eq/minJg of kidney
wt) as compared with control animals and a signifi-
cantly lower GFR (773.7 26.0 .d1minIg of kidney
wt). The pattern of gentamicin delivery along the
nephron was altered by furosemide such that there
was no significant difference between the fractional
delivery of gentamicin to the late proximal or distal
tubules. As in the control animals, there was no
relationship between the delivery of gentamicin and
the TF/P1 values in samples obtained from the dis-
tal tubules. The fractional excretion of gentamicin
Table!. Plasma concentration of 3H-gentamicin and fractional excretion of 3H-gentamicin in the initial and final clearance periodsa
Plasma 3H-gentamicin
dpml1ii
Fractional excretion of gentamicin
%
Initial FinalInitial Final
Group 1 (control) 1057.8 84.0 1074.8 85.2 80.3 3.0 77.5 2.9
Group2(furosemide) 1221.0 100.3 1331.4 123.9 81.1 5.2 81.6 5.9
Group3(sodium bicarbonate) 927.9 93.8 975.4 124.0 107.2 6.8 101.4 3.9
Group4(saline) 1000.9 100.5 987.4 77.1 103.9 4.9 103.4 6.5
Groups(gentamicin-loaded) 1713.3 97.7 1617.8 116.2 61.6 5.2 68.7 4.7
Values are the means SEM.
Table 2. Clearance resultsa
Group 1 Group 2 Group 3
(control animals, (furosemide, (bicarbonate,
N= 10) N=9) N=7)
Group 4
(saline,
N=7)
Group 5
(gentamicin-loaded,
N=6)
GFR,pJ/minlgkidneywt
Cn,amicin,pJ/minIgkidneywt
1031.9 35.9 7737 26.0" 1100.3 67.5
(32) (27) (20)
839.6 39.5 585.4 25.1 1184.2 63.6
1349.2 87.6
(16)
1412.6 93.7
862.2 39.9"
(15)
564.4 45.0
FEntamicin, % 79.7 1.6 79.1 3.0 106.0 2.9" 103.4 3.3" 6.4.7 3.0"
Absolute reabsorption of 154.6 16.2 166.1 18.1 —33.9 14.9" —26.7 17.4" 248.8 20.7"
gentamicin, pg4ti GFR
UNaV,p.Eqlmin/gkidneywt 0.07 0.01 8.44 0.62" 4.82 0.33" 4.10 0.34" 0.07 0.01
UrinarypH ND ND 8.0 0.1 5.9 0.1 ND
UFntamcin,% 85.3 2.9 85.7 2.0 91.0 4.4 85.7 4.6 94.5 2.4c
a Values are the means SEM. Numbers in parentheses are the number of animals or collection periods. C is clearance; FE, fractional
excretion; UF, ultrafilterability; ND, not determined.
P < 0.001, compared with values obtained in control animals (group 1).
P < 0.05, compared with values obtained in control animals (group 1).
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Table 3. Micropuncture results°
Group 1
(control animals)
Group 2 Group 3
(furosemide) (bicarbonate)
Group 4
(saline)
GroupS
(gentamicin-loaded)
Late proximal tubule
TF/P,
SNGFR,nl/min
2.83 0.23
(20)
34.6 2.4
3.03 0.18 2.32 0.11
(16) (15)
25.9 1.3 48.7 2.5
1.94 0.08
(13)
47.1 3.6
2.79 0.23
(14)
28.4 2.9
FDntamicin,% 65.5 5.3 67.7 70" 72.4 7.1" 66.8 8.4" 60.8 5.7"
Absolute reabsorption of 0.28 0.04 0.29 005b 0.18 0.03" 0.18 0.04" 0.41 0.04c
gentamicin,pg/nl GFR
TF/P,
SNGFR,nl/min
10.8 1.6
(20)
44.7 4.5
Distal tubule
5.39 0.55 6.81 0.89
(23) (13)
24.1 2.2 38.9 2.8
6.19 0.38
(19)
47.7 3.8
9.27 1.22
(15)
24.6 2.8
FDentamicin,% 30.7 37e 51.2 44d 80.6 65d 27.8 34b.e 24.4 56b,e
Absolute reabsorption of 0.46 0.03 0.32 0.03 0.13 0.03" 0.38 0.03 0.73 0.06"
gentamicin, pg/ni GFR
FDnt,,miein,% 79.7 l.fi
(32)
Urine
79.1 3.O 106.0 2.9"'
(27) (20)
103.4 3.3'
(16)
64.7 3.0"'
(15)
Values are the means SaM. Numbers in parentheses are the number of sample collections or collection periods. FD is fractional
delivery; FE, fractional excretion. FD and FE values are corrected for serum binding of gentamicin.
"P = NS, compared with control.
"P < 0.05, compared with control.
d P < 0.001, compared with control.
P < 0.001, compared with late proximal tubule of the same group.
P < 0.001, compared with distal tubule of the same group.
in the urine, however, was significantly higher than
that to the distal tubule (79.1 3.0 vs. 51.2 4.4%,
P < 0.001).
Volume expansion with isotonic sodium chloride
or sodium bicarbonate resulted in a similar natriu-
retic response. Urine pH, however, was significant-
ly different between these two groups of animals,
averaging 8.0 0.1 in rats receiving an infusion of
sodium bicarbonate and 5.9 0.1(P <0.001) in rats
receiving saline. Both groups of animals had a frac-
tional excretion rate of gentamicin in the urine that
was significantly higher than that of the control ani-
mals (P < 0.001). The pattern of delivery of gen-
tamicin along the nephron was different in animals
receiving bicarbonate as compared with those in-
fused with saline. In the animals infused with bi-
carbonate, there was no difference in the fractional
delivery rate of gentamicin between the late proxi-
mal and distal tubules. In the group of animals re-
ceiving saline, however, there was a significant de-
crease in the fractional delivery rate of gentamicin
from the late proximal tubule (66.8 8.4%) to the
distal tubule (27.8 3.4%, P < 0.001). There was
no evidence for transport of the drug in the distal
tubules. In both volume-expanded groups, the frac-
tional excretion of gentamicin in the urine was sig-
nificantly higher than that in the distal tubule.
The animals that had undergone gentamicin load-
ing for 3 days had a significantly lower GFR than
the control animals did (862.2 39.9 vs. 1031.9
35.9 dJminIg of kidney wt, P < 0.001). The clear-
ance of gentamicin was also lower in the gen-
tamicin-loaded animals, such that the fractional ex-
cretion averaged 64.7 3.0%, as compared with
79.1 1.6% in the controls (P < 0.001). The frac-
tional delivery of gentamicin along the length of the
nephron segments examined was the same in this
group of animals as it was in the controls. The
plasma level of gentamicin in this group of animals
was determined by radioimmunoassay and aver-
aged 0.94 0.08 p.gIml. This value was significantly
higher than that of the control group of 0.67 0.05
(P < 0.01) as estimated from isotope counts. The
absolute rates of absorption in the proximal tubule,
distal tubule, and urine were all significantly higher
than were the rates for the corresponding nephron
segment in the group 1 animals (0.41 0.04 vs.
0.28 0.04 pg!nl GFR, P < 0.05; 0.73 0.06 vs.
0.46 0.03 pg!nl GFR, P < 0.001; and 248.8 20.7
vs. 154.6 16.2 pg/p.l GFR, P < 0.001, respec-
tively).
Discussion
Before discussion of the results of the present in-
vestigations, certain aspects of the experimental
design require consideration. First, the present
experiments were designed to examine the renal
handling of trace quantities of gentamicin in the rat.
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Thus, application of the findings in these studies to
other species, to circumstances where large
amounts of the drug are infused, or to conditions
where the drug is administered for longer periods of
time must be taken with caution. Second, for an or-
ganic base compound that is taken up and seques-
tered in tissue, the validity of clearance and micro-
puncture results depends in part on attaining a
steady state. As noted in Table 1, and in the studies
of others [4], within 90 mm of starting the infusion
of gentamicin and over the 90 to 120 mm of the ex-
perimental period, the plasma disintegrations per
minute remained constant. The fractional excretion
of gentamicin was also constant over this time peri-
od. These findings were true for the experiments as
a whole as well as in each of the individual experi-
mental protocols. Third, the calculation of the ex-
cretion rates of gentamicin depends on the estimate
of the ultrafilterability of the drug. The data summa-
rized in Tables 2 and 3 are derived by determining
the ultrafilterability in each individual experiment
from aortic blood obtained at the end of the experi-
ment. Ultrafilterability was determined in Amicon
cones in a centrifuge. The values derived are some-
what lower than those reported recently in the rat
by Pastoriza-Munoz, Bowman, and Kaloyanides
[4]. In these latter studies, ultrafilterability was also
determined by equilibrium dialysis in pooled rat
serum that contained higher concentrations of the
drug than were present in our animals. Nonethe-
less, the differences were small, and the inter-
pretation of the results is not significantly altered if
the results are recalculated by the estimate of ultra-
filterability from the studies of Pastoriza-Munoz et
al, or an average value determined for the present
studies by centrifugation.2
Certain differences in the gentamicin-loaded rats
render this group not entirely analogous to the hy-
dropenic, furosemide-treated, or volume-expanded
animals. Accordingly, the results obtained in the
gentamicin-loaded rats will be considered separate-
ly after consideration of the results in the other
groups. In nondiuretic control animals, the fraction-
al excretion of gentamicin in the urine averaged
79.7%, indicating net reabsorption. The fractional
2As noted in the results section, we have also determined the
ultrafiltration of gentamicin by equilibrium dialysis. When the
equilibrium dialysis was performed in a manner identical to that
reported by Pastoriza-Munoz et al, plasma binding of gentamicin
was 92.4%, a value in excellent agreement with that previously
reported [4]. But when the total concentration of drug was closer
to that of our acute studies (excluding the gentamicin-loaded ani-
mals), the plasma binding was 84.7%, a value similar to that de-
termined by centrifugation.
excretion rate was not significantly influenced by
the infusion of furosemide but was significantly
higher in animals in which the extracellular fluid
volume was expanded. In these latter studies, the
fractional excretion of gentamicin approximated the
GFR. Similar results were obtained when the extra-
cellular fluid volume was expanded with sodium
chloride or sodium bicarbonate, suggesting that the
pH of the final urine did not have a significant effect
on the overall clearance of the drug.
In all groups studied, the rate of fractional deliv-
ery of gentamicin to the late proximal tubule was
not significantly different, indicating that neither fu-
rosemide, saline, or sodium bicarbonate influences
gentamicin transport in this segment. The mecha-
nism of gentamicin absorption in the proximal tu-
bule can not be determined from the present stud-
ies. TF/UFGentamicin values ranged between 0.97 and
3.72 in the proximal tubule and thus do not provide
direct evidence for active transport. In the recent
studies of Pastoriza-Munoz et al, gentamicin was
microinjected directly into the proximal tubule [4].
Although such an experimental approach imposes a
transepithelial concentration gradient across the
cells, these investigators also provided evidence
that the absorptive process was saturable. More-
over, autoradiographic studies suggest that gen-
tamicin absorption in the proximal tubule repre-
sents a process of pinocytosis [12, 13]. Taken to-
gether, these results indicate the presence of an
absorptive flux for gentamicin in the proximal con-
voluted tubule.
In the quoted studies of Pastoriza-Munoz et al,
evidence for gentamicin absorption was obtained,
not only in the superficial proximal convoluted tu-
bule, but also at nephron sites between the superfi-
cial proximal and distal tubules [4]. The present
studies confirm this finding in that, in some of the
groups of animals, the fractional delivery rate to the
distal tubule was significantly lower than that to the
late proximal tubule. The fractional rate of absorp-
tion across the pars recta and loop of Henle, how-
ever, was greater than that estimated by Pastoriza-
Munoz et al by the microinjection technique. It is
important to note, however, that significant dif-
ferences in these studies do exist. The micro-
injection technique requires high urine flow rates,
and the infusion of mannitol and saline is usually
used to attain this end. Under certain experimental
conditions, as noted in our sodium bicarbonate-in-
fused and furosemide-infused groups of animals,
little or no gentamicin absorption across the superfi-
cial ioop of Henle may be evident. But in the non-
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diuretic control animals, animals preloaded with
gentamicin, and in animals infused with 3% body wt
isotonic saline, the delivery of gentamicin to the dis-
tal tubule was significantly lower than it was to the
late proximal tubule. As noted in the results, there
was no correlation between TF/P1 values obtained
from the distal tubule and the fractional delivery
rate of gentamicin in any of the groups of animals,
suggesting that gentamicin is not absorbed in the su-
perficial distal tubule. The differences in the frac-
tional delivery rates of gentamicin between the su-
perficial proximal and distal tubules, therefore, in-
dicate an absorptive site for gentamicin in either the
pars recta or the descending or ascending limb of
Henle's loop. The nature of this process, however,
can not be directly determined from the present
studies.
A striking finding was the differences between the
delivery of gentamicin to the distal tubule and the
fractional excretion rate of the drug determined in
the urine. In each group of animals, the fractional
excretion of gentamicin in the urine was significant-
ly higher than it was in the distal tubule. This dis-
parity may indicate the presence of gentamicin se-
cretion in nephron segments beyond the accessible
portion of the superficial distal tubule. Pastoriza-
Munoz et al evaluated the possibility of gentamicin
secretion in the rat by the precession technique and
were unable to demonstrate gentamicin secretion
[4]. Using analogous techniques in 3 animals, we
were also unable to demonstrate gentamicin pre-
cession (unpublished observations). Although these
findings do not absolutely exclude the possibility of
a distal secretory site for gentamicin, they do not
provide any direct evidence to support this possi-
bility. In our view, it seems more likely that there is
a significant degree of nephron heterogeneity for
gentamicin transport. This is most clearly evident in
the volume-expanded animals. In animals receiving
isotonic saline, the delivery of gentamicin to the dis-
tal tubule averaged 27.8%. In animals receiving so-
dium bicarbonate, the distal delivery of gentamicin
averaged 80.6%. Despite these marked differences
in drug delivery to the superficial distal tubule, the
fractional excretion in the urine was the same in
these two groups of animals. It thus seems likely
that a marked degree of heterogeneity for gen-
tamicin transport exists. This conclusion is further
supported by the data of Pastoriza-Munoz et al [4].
In those studies, and in contrast to the present stud-
ies, the fractional excretion of gentamicin was ap-
proximately 100% of the filtered load. Despite the
failure to demonstrate net reabsorption by clear-
ance techniques, the microinjection studies in-
dicated significant rates of reabsorption in the su-
perficial nephrons. One explanation for these seem-
ingly paradoxical results is the presence of different
rates of drug transport in the superficial as com-
pared with the deepest nephrons. Direct studies in
animals in which the deep nephron structures are
accessible to micropuncture, however, will be re-
quired to precisely define the nephron segments in-
volved. Nonetheless, the present investigations in-
dicate a poor correlation between the delivery of
gentamicin out of superficial nephrons and the rates
of urinary excretion. This would imply that the
deeper nephrons are more important in the urinary
elimination of gentamicin.
As noted earlier, the rats loaded with gentamicin
for 3 days are not entirely analogous to the other
animals studied in the present report. The purpose
of including such a group was to determine if the
gentamicin sequestered in the cytosegrosomes of
the renal tubular cells was part of the transport pool
of the drug. As a group, however, the gentamicin-
loaded animals had higher plasma concentrations of
the drug and a lower GFR. Despite these dif-
ferences, the pattern of fractional absorption along
the superficial nephron and the fractional excretion
rate in the urine was similar to that of control ani-
mals. The calculated absolute rates of absorption
were higher. These results suggest that glomerular-
tubular balance for gentamicin handling by the kid-
ney existed and that the higher rates of absolute ab-
sorption reflect the higher delivered load of the
drug. Said in another way, if gentamicin has a Tm
for reabsorption, as recently suggested, the rates of
drug delivery and the intraluminal concentration of
the drug in the present studies were below that re-
quired to demonstrate saturation [4].
In summary, then, the results of the present study
indicate that, first, gentamicin is reabsorbed in the
superficial proximal convoluted tubule of the rat
and that the rate of reabsorption is independent of
the rate of sodium and water absorption, is not af-
fected by furosemide or the state of hydration of the
extracellular fluid, and is not affected by the pre-
sumed bicarbonate concentration in the glomerular
filtrate in the proximal tubule. Second, gentamicin
is also reabsorbed at a nephron site between the ac-
cessible portion of the proximal tubule and the su-
perficial distal tubule under some experimental con-
ditions. The reabsorption across these nephron seg-
ments is inhibited by the infusion of furosemide and
bicarbonate but not by the administration of saline.
Third, and perhaps the most surprising result of the
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present studies, was the poor correlation between
the delivery of gentamicin to the distal tubule and
the fractional excretion of the drug in the urine. The
most likely explanation for these findings is a degree
of nephron heterogeneity for gentamicin transport
not previously recognized. Finally, for the kidney
as a whole, expansion of the extracellular fluid vol-
ume results in an increased excretion of gentamicin.
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